- The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer
Kathrine Bjersand et al, 2017, PLOS ONE CrossRef - Therapeutic potential of combination therapy of soluble VEGF receptor 1 and conventional chemotherapy for ovarian cancer growth
Noriko Sato et al, 2020, Journal of Obstetrics and Gynaecology Research CrossRef - Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis
Amilcar Barreta et al, 2019, Human Pathology CrossRef - Quantitative analysis of the human ovarian carcinoma mitochondrial phosphoproteome
Na Li et al, 2019, Aging CrossRef - The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer
Meryem El Azzouzi et al, 2023, Diagnostics CrossRef - Zebrafish: A Model Organism to Understand Tumor Angiogenesis Mechanism
Krishnasamy Naidu Gopal Hariprabu et al, 2022, Zebrafish Model for Biomedical Research CrossRef - The functional consequences and prognostic value of dosage sensitivity in ovarian cancer
Zichuang Yan et al, 2017, Molecular BioSystems CrossRef - Ang-1 and VEGF: central regulators of angiogenesis
Yuanqin Zhao et al, 2024, Molecular and Cellular Biochemistry CrossRef - Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
Venus Dalal et al, 2018, Clinica Chimica Acta CrossRef - Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients
Beata Kotowicz et al, 2017, PLOS ONE CrossRef - Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Allison L. Hunt et al, 2021, iScience CrossRef - Two Biosensors for the Determination of VEGF-R2 in Plasma by Array SPRi
Lukasz Oldak et al, 2022, Molecules CrossRef - Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages�I-II
Ingiridur Skirnisdottir et al, 2018, International Journal of Oncology CrossRef - Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients
Valéria Tavares et al, 2021, The Pharmacogenomics Journal CrossRef - Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine
Cheng Zhang et al, 2018, Integrative Cancer Therapies CrossRef